We are live on ! Find out more
JGBO

Jiangbo Pharmaceuticals, Inc. Common Stock
JGBO

Delisted

JGBO was delisted on the 31st of May, 2011.

Back to rankings

2 hedge funds and large institutions have $19K invested in Jiangbo Pharmaceuticals, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0% more capital invested

Capital invested by funds: $19K → $19K ($0)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
1
Pope Asset Management
Tennessee
$19K – – –

JGBO Hedge Fund Activity: Q3 2014 in Review

2 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Jiangbo Pharmaceuticals, Inc. Common Stock (JGBO) for Q3 2014, worth a combined $19K — unchanged from a quarter earlier.

Fund positioning in JGBO was balanced in Q3 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Jiangbo Pharmaceuticals, Inc. Common Stock (JGBO) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $19K of Jiangbo Pharmaceuticals, Inc. Common Stock stock for Q3 2014, unchanged quarter-over-quarter.
  • 0 funds opened new Jiangbo Pharmaceuticals, Inc. Common Stock positions in Q3 2014 and 0 closed out.

Based on aggregated 13F filings for Q3 2014.